ImmunoTek Bio Centers is an emerging biotech company committed to the safe collection and procurement of human blood plasma f ... rom the public. The management team has nearly 100 years of collective experience in the blood, plasma, and biopharma industries. Through contracts and strategic agreements with pharmaceutical companies, ImmunoTek is fully capable of constructing, opening, FDA/EU licensing, and managing multiple plasma collection sites and plasma supply contracts to meet ongoing demand in the plasma proteins therapeutics market. The growth of current therapeutic drugs and vaccines and additional new therapeutic indications are expected to put considerable strain on the global blood plasma supply. The former Chief Operating Officer, Chief Financial Officer, and VP Operations of International BioResources, LLC (“IBR”) formed a new company called ImmunoTek Bio Centers, LLC and acquired the total assets of IBR in November 2012. These assets included all intellectual property used to operate a plasma collection company e.g: FDA Approved Standard Operating Procedures (“SOPs”), Training Manuals, New Center Development Plans, and all other assets of IBR. read more